BD Biosciences to Establish Manufacturing in Puerto Rico

/0 Comments/in , , /by

Franklin Lakes, NJ—BD Biosciences, a segment of BD (Becton, Dickinson and Company), today announced plans to expand manufacturing in Puerto Rico and to begin production of selected reagent products there starting in 2007.The $42 million capital investment project is expected to create over 100 new positions at the Cayey, Puerto Rico facility, which currently supports […]

Read more →

Invitrogen, Procter & Gamble Extend Research Agreement; Successful RNAi Research Service Agreement Continues with Two Year Extension

/0 Comments/in , /by

CARLSBAD, Calif.–Invitrogen Corporation (Nasdaq:IVGN), a leading life sciences company, today announced the extension of an RNAi research service agreement with Procter & Gamble Pharmaceuticals, Inc. (P&GP), a division of The Procter & Gamble Company (NYSE:PG). The research service agreement is now in its fourth year and will continue through December 2006. Through use of Invitrogen’s […]

Read more →

Dharmacon and Alcon to Collaborate on Discovery of New Therapies for Eye Diseases Using RNAi

/0 Comments/in , , /by

LAFAYETTE, Colo. — Dharmacon, Inc., a business unit of the Fisher Biosciences group, and the world’s leading supplier of innovative RNA and RNA interference (RNAi) research products, today announced a collaboration to develop a new class of therapeutic agents based on RNA interference with Alcon Research, Ltd. and Alcon Manufacturing, Ltd., affiliates of Alcon, Inc. […]

Read more →

Fisher Biosciences and University of Michigan Collaborate to Develop New Life-Sciences Technologies

/0 Comments/in , , , , , /by

HAMPTON, N.H.–On behalf of its Biosciences group, Fisher Scientific International Inc. has launched a five-year collaboration with the University of Michigan to develop new tools for genomic and proteomic research. The collaboration promotes opportunities for Fisher to combine its expertise with research at the Center for Chemical Genomics (CCG) within the University of Michigan’s Life […]

Read more →

Ambion and GE Healthcare Announce Licensing and Supply Agreeement to Advance Micro-RNA Microarray Research

/0 Comments/in , , /by

Austin, TX, USA––Ambion, Inc., an Austin-based life sciences company that develops technologies for RNA analysis, and GE Healthcare, a unit of General Electric Company (NYSE: GE), today announced that they had entered into a license and supply agreement under which GE Healthcare will manufacture for Ambion microRNA (miRNA) microarrays utilizing GE Healthcare’s CodeLink™ Bioarray technology. […]

Read more →